Daria Akimova

Daria Akimova

Auto-generated profile, based on publicly available information

Daria Akimova

Department of Functional Genomics, Research Centre for Medical Genetics, Russia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Elena MerkuryevaElena Merkuryeva
Elena Merkuryeva
TNTatyana S. Nagornova
Tatyana S. Nagornova
VKVladimir Kenis
Vladimir Kenis
ADAnna S. Deviataikina
Anna S. Deviataikina
DADaria B. Akimova
Daria B. Akimova
Tatiana MarkovaTatiana Markova
Tatiana Markova
Osteogenesis imperfecta type VI is a rare autosomal recessive disorder characterized by bone fragility and defective mineralization, caused by pathogenic variants in the SERPINF1 gene. This study aimed to expand the understanding of OI type VI by analyzing clinical, radiological, and molecular findings in four patients from three unrelated families. Genotyping revealed two novel SERPINF1 variants, c.185G>T (p.Gly62Val) and c.992_993insCA (p.Glu331Asnfs), in a compound heterozygous state in one patient, and a known pathogenic variant, c.261_265dup (p.Leu89Argfs26), in a homozygous form in three patients. Clinical manifestations included early-onset fractures, severe skeletal deformities, impaired mobility, and growth failure. Radiological assessments revealed multilevel and multiplanar bone deformities and metaphyseal widening. RNA analysis demonstrated that the c.992_993insCA variant results in a truncated PEDF protein without triggering nonsense-mediated decay. Population screening identified a carrier frequency of 0.0044 for the c.261_265dup variant, suggesting a founder effect in the Tuvinian population. These findings expand the mutational spectrum of the SERPINF1 gene and provide new insights into the phenotypic variability of OI type VI. Our results highlight the importance of genetic screening in isolated populations and emphasize the need for further research to develop more effective therapeutic approaches for patients with limited response to bisphosphonate therapy.

26 August 2025 in Clinical Genetics
Verified
Journal Article
Open access
DADaria Akimova
Daria Akimova
NSNatalia Semenova
Natalia Semenova
TCTatiana Cherevatova
Tatiana Cherevatova
MSMikhail Yu Skoblov
Mikhail Yu Skoblov
Dyskeratosis congenita (DC) is a rare genetic disorder caused by impaired telomere maintenance, leading to diverse clinical manifestations, including bone marrow failure, mucocutaneous abnormalities, and multi‐organ dysfunction. Here, we report a 14‐year‐old male patient presenting with microcephaly, developmental delay, synostoses, cerebellar hypoplasia with ataxia, and an immunodeficiency condition, but lacking classical DC features such as nail dystrophy and skin hyperpigmentation. WGS revealed two variants in the PARN gene: a known pathogenic missense variant (c.1045C > T, p.Arg349Trp) and a novel intronic variant (c.178‐28T > C). Functional RNA analysis demonstrated that the intronic variant disrupts the branch point sequence, leading to exon 4 skipping and nonsense‐mediated decay (NMD) of a significant proportion of transcripts. This study confirms the pathogenicity of the intronic variant and underscores the importance of functional validation in interpreting noncoding variants, particularly in genetically heterogeneous disorders like DC. Our findings expand the molecular and phenotypic spectrum of PARN ‐related DC and highlight the utility of WGS reanalysis and RNA studies in resolving diagnostically challenging cases.

5 January 2024 in Frontiers in Genetics
Verified
Journal Article
Open access
DADaria Akimova
Daria Akimova
TMTatiana Markova
Tatiana Markova
MAMaria Ampleeva
Maria Ampleeva
MSMikhail Skoblov
Mikhail Skoblov
SHFM (Split Hand/Foot Malformation) is a heterogeneous group of disorders characterized by the presence of clefts in the hands and feet, along with syndactyly of the digits. In this article, we describe a family in which two members exhibit characteristic developmental abnormalities associated with SHFM, presenting with variable clinical features. Using whole-genome sequencing, we identified a microduplication of a chromosomal segment on locus 10q24.32, specifically spanning positions 102934495 to 103496555, encompassing genes BTRC, POLL, FBXW4 and LBX1 in the proband. Genomic duplications, including these genes, were previously described in patients diagnosed with the third type of SHFM. We validated the presence of this structural rearrangement in 7 family members, including the proband and the proband’s father. Remarkably, further investigation demonstrated that the detected duplication exhibits a mosaic state in the phenotypically normal paternal grandmother of the proband, thereby providing a plausible explanation for the absence of a pathological phenotype in her.

Verified
Journal Article
Open access
PDF file
DODarya Osipova
Darya Osipova
EDElena L. Dadali
Elena L. Dadali
VKVladimir Kenis
Vladimir Kenis
EMEvgenii Melchenko
Evgenii Melchenko
DADaria Akimova
Daria Akimova
Tatiana MarkovaTatiana Markova
Tatiana Markova
Spondyloepimetaphyseal dysplasia type Isidor-Toutain (RPL13-SEMD) is an autosomal dominant skeletal dysplasia caused by heterozygous pathogenic variants in the RPL13 gene, encoding the ribosomal protein eL13. To date, 13 pathogenic variants in RPL13 have been reported, all clustering within intron 5 and exon 6, suggesting this hotspot region is critical for the function of ribosomes in skeletal tissues. Here, we present clinical and radiological characteristics of seven individuals, five children and two adults, from four unrelated families with RPL13-SEMD caused by two novel variants (c.477+5G>C and c.539_541del) and two previously reported variants (c.477+1G>C and c.548G>A) in RPL13. RNA analysis demonstrated that c.477+5G>C leads to a 54-nucleotide extension of exon 5, resulting in an 18-amino acid insertion. The phenotypic spectrum ranged from mild manifestations, such as Blount-like tibial deformity without significant short stature or Perthes-like femoral epiphyseal changes, to severe skeletal deformities with disproportionate short stature, accompanied by extraskeletal features (e.g., penoscrotal hypospadias, coccygeal abnormalities). For the first time, we describe Blount-like tibial deformity as a feature of this dysplasia, which resolves with age. Our study provides additional insights into the clinical, radiological, and genotypic features of RPL13-SEMD through detailed analysis of patients and their affected relatives.

8 January 2026 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
DADaria Akimova
Daria Akimova
TMTatiana Markova
Tatiana Markova
MOMaria Orlova
Maria Orlova
VKVladimir Kenis
Vladimir Kenis
MSMikhail Skoblov
Mikhail Skoblov
Acromesomelic dysplasia comprises a group of rare skeletal disorders characterized by dwarfism with anomalies predominantly affecting the middle and distal segments of the limbs. Based on genetic variants, five types are recognized, with significant phenotypic variability even within a single type. Here, we describe a girl presenting with borderline short stature and mild disproportion due to acro- and mesomelic shortening of the limbs. Radiographic examination revealed shortening of the radius and ulna, mild brachydactyly, absence of iliac flaring and metaphyseal alterations of the long bones, and biconcave appearance of the femoral necks and II-IV metacarpals, and an elongated styloid process of the ulna. Using WGS, we identified two novel variants in the PRKG2 gene: a frameshift variant (NM_006259.3:c.1074del (p.Ala359LeufsTer24)) and a missense variant (NM_006259.3:c.1630G>T (p.Asp544Tyr)). Functional analysis unveiled a unique dual pathogenic mechanism: the missense variant creates a cryptic splice site, resulting in two aberrant protein products - an in-frame deletion and a missense substitution. We hypothesize that these alterations cause a partial, rather than a complete, loss of protein function, which may account for the patient’s attenuated clinical phenotype.

20 October 2026 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
DADaria Akimova
Daria Akimova
AVAnait Voskanyan
Anait Voskanyan
AOAnna Orlova
Anna Orlova
MSMikhail Skoblov
Mikhail Skoblov
Pathogenic deep intronic variants are an underrecognized cause of inherited disorders because they are typically missed by exon-focused sequencing and often require functional validation. We describe a patient with classic CLN7 disease caused by a previously unreported deep intronic variant in MFSD8 . The patient presented with developmental regression, progressive epilepsy, cerebellar ataxia, and cerebral and cerebellar atrophy. Trio whole-genome sequencing identified a homozygous MFSD8 variant, NM_001371596.2:c.999-556C>G, absent from population databases and previous reports. SpliceAI predicted activation of cryptic splice sites leading to inclusion of a 98-nt pseudoexon. RNA analysis of patient-derived fibroblasts confirmed aberrant pseudoexon inclusion, resulting in a frameshift and premature termination codon, with the aberrant transcript accounting for 84% of total MFSD8 transcripts. A minigene assay independently reproduced the splicing defect, confirming that the variant disrupts normal MFSD8 splicing. This study expands the mutational spectrum of MFSD8 and provides functional evidence supporting the pathogenicity of a novel deep intronic splice-altering variant. Our findings further demonstrate the value of combining whole-genome sequencing with transcript analysis for the molecular diagnosis of unsolved rare neurogenetic disorders.